博瑞生物 (872404.OC)

+ 收藏

现金流量表(博瑞生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 17,278,063.3953,403,113.3119,811,621.1152,482,230.1612,414,636.07
 收到其他与经营活动有关的现金(元) 30,745.641,505,079.70106,741.222,175,996.59118,840.09
 经营活动现金流入小计(元) 17,308,809.0354,908,193.0119,918,362.3354,658,226.7512,533,476.16
 购买商品、接受劳务支付的现金(元) 19,324,712.5618,078,286.1416,644,169.3738,514,581.856,130,566.93
 支付给职工以及为职工支付的现金(元) 563,289.772,022,816.65825,335.031,454,302.85818,413.00
 支付的各项税费(元) 100,526.424,816,215.832,061,194.872,328,500.041,814,514.80
 支付其他与经营活动有关的现金(元) 2,053,931.0026,444,876.113,103,089.662,729,430.742,144,152.67
 经营活动现金流出小计(元) 22,042,459.7551,362,194.7322,633,788.9345,026,815.4810,907,647.40
 经营活动产生的现金流量净额(元) -4,733,650.723,545,998.28-2,715,426.609,631,411.271,625,828.76
二、投资活动产生的现金流量
 购建固定资产、无形资产和其他长期资产支付的现金(元) 150,420.894,634,035.01218,346.534,690,877.231,041,261.59
 投资活动现金流出小计(元) 150,420.894,634,035.01218,346.534,690,877.231,041,261.59
 投资活动产生的现金流量净额(元) -150,420.89-4,634,035.01-218,346.53-4,690,877.23-1,041,261.59
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 13,800,000.0025,000,000.007,000,000.0018,750,000.0011,000,000.00
 收到其他与筹资活动有关的现金(元) 4,801,543.2810,732,096.744,454,771.919,875,600.004,507,168.00
 筹资活动现金流入小计(元) 18,601,543.2835,732,096.7411,454,771.9128,625,600.0015,507,168.00
 偿还债务支付的现金(元) 6,000,000.0018,750,000.004,250,000.0024,949,003.4110,250,000.00
 分配股利、利润或偿付利息支付的现金(元) 1,037,062.231,951,884.671,880,086.102,066,213.831,223,227.19
 支付其他与筹资活动有关的现金(元) 5,605,083.3420,420,802.008,683,541.103,040,000.007,665,000.00
 筹资活动现金流出小计(元) 12,642,145.5741,122,686.6714,813,627.2030,055,217.2419,138,227.19
 筹资活动产生的现金流量净额(元) 5,959,397.71-5,390,589.93-3,358,855.29-1,429,617.24-3,631,059.19
五、现金及现金等价物净增加额(元) 1,075,326.10-6,478,626.66-6,292,628.423,510,916.80-3,046,492.02
 加:期初现金及现金等价物余额(元) 150,461.216,629,087.876,629,087.873,118,171.073,118,171.07
 期末现金及现金等价物余额(元) 1,225,787.31150,461.21336,459.456,629,087.8771,679.05
补充资料:
 净利润(元) 97,391.782,933,517.93113,697.99808,872.882,934,701.46
 固定资产和投资性房地产折旧(元) 1,846,036.332,843,619.791,296,157.452,378,659.111,467,347.59
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 1,846,036.332,843,619.791,296,157.452,378,659.111,467,347.59
 无形资产摊销(元) 65,922.48131,844.9665,922.48131,844.9665,922.48
 长期待摊费用摊销(元) 43,887.4885,028.0643,553.7893,939.7246,969.86
 固定资产报废损失(元) -45,590.29---
 财务费用(元) 1,037,062.231,936,356.891,880,086.102,267,794.391,223,227.19
 递延所得税(元) -31,360.42-8,185.5350,079.1940,447.91-305,187.17
  其中:递延所得税资产减少(元) -31,360.42-8,185.5350,079.1940,447.91-305,187.17
 存货的减少(元) -6,541,694.2730,544,608.5418,082,698.98-34,108,828.022,092,399.80
 经营性应收项目的减少(元) 1,933,984.77-39,428,586.25-21,500,547.1336,847,152.53-7,349,154.04
 经营性应付项目的增加(元) -2,448,670.404,224,069.17-2,413,214.15778,866.27-584,979.52
 现金的期末余额(元) 1,225,787.31150,461.21336,459.456,629,087.8771,679.05
 减:现金的期初余额(元) 150,461.216,629,087.876,629,087.873,118,171.073,118,171.07
 现金及现金等价物的净增加额(元) 1,075,326.10-6,478,626.66-6,292,628.423,510,916.80-3,046,492.02
公告日期 2024-08-262024-04-292023-08-282023-04-282022-08-30
审计意见(境内) 带强调事项段的无保留意见保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院